Ralf Nilsson

AstraZeneca (Sweden)

Papers

1

Total Citations

328

H-Index

1

About

Ralf Nilsson has fundamentally transformed lipidomics methodology through his pioneering work in developing high-throughput, environmentally sustainable lipid extraction techniques. His most celebrated contribution, the BUME method—a novel automated chloroform-free 96-well total lipid extraction protocol for blood plasma—has garnered over 328 citations since its publication in 2012. This innovation addressed a critical bottleneck in lipid research by replacing hazardous chloroform with safer solvents while enabling full automation on standard robotic platforms, dramatically accelerating sample processing without compromising extraction efficiency. Beyond this landmark achievement, Nilsson’s research portfolio centers on advancing analytical workflows for comprehensive lipid profiling, with particular emphasis on reducing technical variability and increasing throughput in clinical and epidemiological studies. His work has been instrumental in bridging the gap between traditional labor-intensive lipid extraction and modern high-throughput metabolomics, making large-scale lipid biomarker discovery feasible. By prioritizing both analytical rigor and practical automation, Nilsson has empowered researchers worldwide to conduct lipid analyses with unprecedented speed and reproducibility, cementing his reputation as a key innovator in the field of bioanalytical chemistry.

Research Focus

Key Achievements

1
H-Index
1
Papers
328
Total Citations
328
Avg Citations/Paper
🏆 Most Cited Paper
The BUME method: a novel automated chloroform-free 96-well total lipid extraction method for blood plasma
328 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: AstraZeneca (Sweden)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago